These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?]. Stimpel M, Kaufmann W, Wambach G. Z Kardiol; 1988; 77 Suppl 2():92-8. PubMed ID: 2970180 [Abstract] [Full Text] [Related]
14. Circulating atrial natriuretic polypeptide during exercise in patients with essential hypertension. Nishikimi T, Kohno M, Matsuura T, Kanayama Y, Akioka K, Teragaki M, Yasuda M, Oku H, Takeuchi K, Takeda T. J Hypertens Suppl; 1986 Dec 20; 4(6):S546-9. PubMed ID: 2956390 [Abstract] [Full Text] [Related]
15. Plasma level of atrial natriuretic peptide as an indicator of increased cardiac load in uremic patients. Tikkanen I, Metsärinne K, Grönhagen-Riska C, Fyhrquist F. Clin Nephrol; 1990 Oct 20; 34(4):167-72. PubMed ID: 2147876 [Abstract] [Full Text] [Related]
16. Atrial natriuretic peptide (ANP) in chronic obstructive pulmonary disease (COPD): the relationship between plasma ANP and lung function. Effects of exercise and of the calcium antagonist, isradipine, on plasma ANP. A randomised, double-blind, placebo-controlled study. Graudal N, Galløe AM, Storm T, Thamsborg G, Christensen HR. Horm Metab Res; 1992 Mar 20; 24(3):130-3. PubMed ID: 1533606 [Abstract] [Full Text] [Related]